All India Institute of Medical Sciences, Bhopal
5
1
1
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
40%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in India
Role: collaborator
Improving Outcomes in Depression in Primary Care in a Low Resource Setting
Role: collaborator
Impact, Cost, and Sustainability of a Customized, Low-Cost Intervention to Reduce Cardiovascular Disease Burden in India: A Cluster Randomized Trial
Role: collaborator
OptimizeD Pilot Study
Role: collaborator
An RCT of 19G EBUS-TBNA Needle in Suspected Sarcoidosis
Role: collaborator
All 5 trials loaded